semaglutide acetate FDA warns about compounded versions of semaglutide, used for diabetes, weight loss FDA warns dangers of using

The Humira case established that a well-constructed biologic patent thicket, combined with a timely product hop, can convert a patent cliff into a managed revenue step-down over three to five years rather than a collapse in 12 months

Its not the biggest market but its a proof point that the generics pathway works, and its a live commercial precedent that every other generic company is now citing in their regulatory submissions

123 Besides, synaptic plasticity-related proteins, including CREB, pCREB, brain-derived neurotrophic factor (BDNF), and activity-regulated cytoskeleton (Arc) proteins, are significantly reduced

The goal is alignment